Clinical trial

Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients

NCT00350792

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-08-01

PhasePHASE2

Study timeline

Study start (unknown)2006-08-01Date precision: month

Registry last updated2010-10-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancerunresolved

Interventions

pemetrexedDRUG · verified · RxNorm: pemetrexed

carboplatinDRUG · verified · RxNorm: carboplatin

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

LilleFrance1 NantesFrance1 CaenFrance1 BrestFrance1 Vandœuvre-lès-NancyFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00350792 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.